Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ASAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ATP9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102725420 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MAP3K3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM50B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCTN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PIR-FIGF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSTM1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLI3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSD17B14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B3GALNT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAPGEF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPAR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAZ2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHD1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTNA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on